Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes.
Atabek
Mehmet Emre
ME
Pirgon
Ozgur
O
Unal
Ekrem
E
D000293:Adolescent; D000965:Antimony; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001786:Blood Glucose; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000175:diagnosis; D005260:Female; D006801:Humans; D007717:Knee / Q000473:pathology; D016773:Leishmaniasis, Cutaneous / Q000150:complications* / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D001786:Blood Glucose; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony